Approved Drugs Dissolve Mutant Polymerase Aggregates and Restore Motor Function in Mice
Two already approved drugs, diltiazem and sulbactam, dissolved mutant POLGA aggregates and restored mitochondrial DNA replication and motor function in ...
Two already approved drugs, diltiazem and sulbactam, dissolved mutant POLGA aggregates and restored mitochondrial DNA replication and motor function in ...
The first knock-in mouse carrying the recurrent human RMND1 p.(Asn238Ser) mutation recapitulates severe multisystem mitochondrial disease, revealing widespread OXPHOS defects ...
An international study shows that functional testing on cells grown from a small skin biopsy can diagnose mitochondrial disease, often ...
A nationwide English cohort study of 1,107 genetically confirmed patients shows that survival in primary mitochondrial disease is far better ...
A new Journal of Neurology case report describes recurrent posterior stroke-like brain lesions that were ultimately revealed to be manifestations ...
A study of eleven Han Chinese children with the m.3243 A>G mitochondrial DNA mutation reveals striking phenotypic variability, a mean ...
A four-week trial of nicotinamide riboside in eight patients with mitochondrial DNA disease shows the first human evidence of molecular ...
Six leading researchers outline the opportunities, challenges and emerging priorities for advancing research and therapy development in rare metabolic diseases.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine